VRML News and Press, Aspira Womens Health From 03/12/19

AUSTIN, Texas, March 12, 2019 (GLOBE NEWSWIRE) -- Vermillion, Inc. (Nasdaq: VRML), a bioanalytical-based women’s health company focused on gynecologic disease, today announced that it will report financial results for the fourth quarter and year ended December 31, 2018 on Thursday,...

AUSTIN, Texas, Sept. 06, 2018 (GLOBE NEWSWIRE) -- Vermillion, Inc. (NASDAQ:VRML), a bioanalytical-based women’s health company focused on gynecologic disease, will ring the NASDAQ closing bell today.  “September is an opportunity for us to reach more women and raise ...

Seasoned managed care leader with 30+ years  of managed health experience AUSTIN, Texas, Aug. 21, 2018 (GLOBE NEWSWIRE) -- Vermillion, Inc. (NASDAQ: VRML) , a bioanalytical-based women’s health company focused on gynecologic disease, today announced the appointment of Nanc...